Hudson Bay Capital Management
PVCT.WS

Hudson Bay Capital Management’s PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) PVCT.WS Stock Holding History

Hudson Bay Capital Management’s Portfolio PVCT.WS Stock Details PVCT.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-577,066
Closed -$124K – 299
2015
Q2 		$124K Buy
+577,066
New +$120K ﹤0.01% 216

Other funds holding PVCT.WS

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Hudson Bay Capital Management's PVCT.WS Position: Q3 2015 in Review

Hudson Bay Capital Management sold out of PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) (PVCT.WS) in Q3 2015, closing a stake of 577,066 shares — an estimated $124K sold.

Hudson Bay Capital Management first reported a position in PVCT.WS in Q2 2015 and held it in 1 quarter. The position peaked at $124K in Q2 2015. 2 funds tracked by Wall St. Rank hold PVCT.WS as of Q3 2015.

  • Hudson Bay Capital Management reported no remaining PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) position as of Q3 2015 after selling out during the quarter.
  • Hudson Bay Capital Management sold 577,066 PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) shares in Q3 2015, an estimated $124K.
  • Hudson Bay Capital Management first reported a position in PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) in Q2 2015 and held it in 1 quarter.
  • Hudson Bay Capital Management's PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) position peaked at $124K in Q2 2015.
  • 2 funds tracked by Wall St. Rank held PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) as of Q3 2015.

Based on Hudson Bay Capital Management's 13F filing for Q3 2015, filed 10 Nov 2015.